Global DVT Screening Devices Market Size By Type (Imaging Modalities, Intravasular Ultrasound), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Deep Vein Thrombosis (DVT) Screening Devices Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. The market is driven by the rising incidence of venous thromboembolism (VTE), increasing awareness of preventive healthcare, and technological advancements in diagnostic imaging and portable screening devices. As healthcare providers prioritize early detection of DVT to prevent life-threatening complications such as pulmonary embolism, the demand for non-invasive, rapid, and efficient DVT screening devices is expanding across hospitals, clinics, and outpatient settings.

Drivers:

1. Increasing Incidence of VTE and Sedentary Lifestyles:

A rise in the number of patients with risk factors such as obesity, cancer, immobility, and aging populations is significantly contributing to the demand for DVT screening. The growing prevalence of sedentary lifestyles and post-surgical recovery complications also elevate the risk of thrombosis, prompting proactive diagnostic measures.

2. Advancements in Ultrasound and Imaging Technologies:

Innovations in duplex ultrasound, portable Doppler systems, and AI-powered diagnostic imaging have enhanced the accuracy and convenience of DVT detection. These improvements are making DVT screening more accessible even in low-resource settings.

3. Growing Emphasis on Preventive Healthcare:

Governments and healthcare organizations worldwide are increasingly focusing on early diagnosis and treatment of vascular disorders. This focus is pushing adoption of routine DVT screening in high-risk patient groups.

Restraints:

1. High Cost of Advanced Diagnostic Equipment:

The upfront costs and maintenance requirements of high-end ultrasound and imaging devices can be restrictive for smaller healthcare facilities, especially in developing regions.

2. Limited Availability of Skilled Technicians:

Accurate DVT diagnosis relies on trained professionals to operate screening equipment and interpret results. A shortage of trained sonographers and vascular specialists in some regions hampers market penetration.

Opportunity:

1. Expansion of Portable and AI-Powered DVT Screening Devices:

The emergence of compact, user-friendly, AI-enabled DVT diagnostic devices presents significant opportunities, particularly for remote and resource-constrained environments. These innovations support decentralization of vascular diagnostics and promote telehealth integration.

2. Rising Demand in Emerging Markets:

Rapidly developing healthcare infrastructures and increasing awareness of thrombotic conditions in Asia-Pacific, Latin America, and the Middle East & Africa are creating new avenues for market growth.

Market by System Type Insights:

By system type, the Ultrasound/Duplex Imaging Systems segment held the largest market share in 2023 due to its wide usage in hospital and clinical settings for accurate and non-invasive DVT diagnosis. However, Portable Doppler Devices are expected to witness the highest growth rate through 2031, driven by rising point-of-care adoption and improvements in portability and ease of use.

Market by End-Use Insights:

The Hospitals & Clinics segment accounted for the highest revenue share in 2023, supported by strong infrastructure and frequent screening of high-risk inpatients. The Ambulatory Surgical Centers (ASCs) and Homecare Settings segments are gaining momentum due to the trend toward outpatient and home-based healthcare services.

Market by Regional Insights:

North America dominated the global DVT screening devices market in 2023, owing to high awareness, advanced diagnostic technologies, and supportive reimbursement frameworks. Meanwhile, the Asia-Pacific region is forecasted to experience the fastest CAGR through 2031 due to the expanding geriatric population, growing healthcare access, and increasing incidence of VTE in countries such as China and India.

Competitive Scenario:

Key players operating in the Global DVT Screening Devices Market include:

GE HealthCare

Siemens Healthineers

Koninklijke Philips N.V.

FUJIFILM Holdings Corporation

Canon Medical Systems Corporation

Mindray Medical International Ltd.

SonoScape Medical Corp.

EDAN Instruments, Inc.

These companies are focusing on product innovation, AI integration, and expanding their reach in emerging markets. Recent developments include:

2023: Philips launched a handheld Doppler device integrated with AI for point-of-care DVT screening.

2024: Siemens Healthineers introduced an upgraded duplex ultrasound system with enhanced vascular imaging resolution.

2025: GE HealthCare announced a strategic partnership to expand access to portable ultrasound systems in low-income countries.

Scope of Work – Global DVT Screening Devices Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023–2031) 9.1%

Market Segments System Type (Ultrasound, Doppler, Others); End-use (Hospitals, ASCs, Homecare); Region

Growth Drivers Rising VTE cases, preventive care awareness, tech advancements

Opportunities Portable AI-powered devices, emerging market expansion

Key Market Developments:

June 2023: Philips introduced AI-powered handheld Doppler systems for rapid, bedside vascular screening.

October 2024: Siemens Healthineers released a new duplex imaging device optimized for DVT diagnosis.

January 2025: Mindray launched an affordable, battery-operated DVT screening tool targeting rural clinics in Asia-Pacific.

FAQs:

1. What is the current market size of the Global DVT Screening Devices Market?

The market was valued at USD 1.2 billion in 2023.

2. What is the major growth driver of the Global DVT Screening Devices Market?

The market is driven by the increasing incidence of venous thromboembolism and advancements in diagnostic imaging technologies.

3. Which is the largest region during the forecast period in the Global DVT Screening Devices Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow the fastest through 2031.

4. Which segment accounted for the largest market share in Global DVT Screening Devices Market?

The Ultrasound/Duplex Imaging Systems segment dominated the market by system type in 2023.

5. Who are the key market players in the Global DVT Screening Devices Market?

Key players include GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Mindray.